赛提辛对健康吸烟者的心室再极化参数的影响
Cahit Coşkun1, Derya Tosun2, Bilal Çakır3
1Department of Cardiology, Ministry of Health Demirci State Hospital, Manisa, Türkiye.
概括
在健康吸烟者中,用于戒烟的花素治疗没有显著改变关键心电图 (ECG) 参数,如QT,QTc和Tp-e间隔. 对患有心血管疾病的患者需要进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 锡提辛是一种禁烟辅助剂,作用于尼古丁受体.
- 瓦伦尼克林,具有类似的机制,已经显示了心电图的改变.
- 锡提辛对心电图参数的影响尚未研究.
研究的目的:
- 评估细胞素对心电学参数的影响.
- 具体评估QT,QTc,Tp-e和Tp-e/QTc比率的变化.
- 研究细胞素对心室再极化的影响.
主要方法:
- 对110名完成25天细胞因素治疗方案的患者进行了回顾性分析.
- 排除患有心血管疾病或服用QT延长药物的患者.
- 治疗前后进行了ECG和生物化学评估.
主要成果:
- 在cytisine后的QT,QTc,Tp-e或Tp-e/QTc比率没有显著变化.
- 观察到和水平的微小,正常范围的变化.
- 吸烟史与基线Tp-e/QTc之间没有相关性.
结论:
- 在健康吸烟者中,短期使用细胞素对心室再极化没有显著影响.
- 研究结果表明,在这个群体中,细胞素对短期心电图变化是安全的.
- 建议进行长期和患者特异性研究.
更多相关视频
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Stimulants
812
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
812
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.7K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K


